Bilobil intense capsules

Land: Armenia

Språk: engelsk

Kilde: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Last ned Preparatomtale (SPC)
10-03-2023

Aktiv ingrediens:

ginkgo biloba folies dry extract

Tilgjengelig fra:

KRKA d.d.

ATC-kode:

N06DX02

INN (International Name):

ginkgo biloba folies dry extract

Dosering :

120mg

Legemiddelform:

capsules

Enheter i pakken:

(20/2x10/) in blister

Resept typen:

OTC

Autorisasjon status:

Registered

Autorisasjon dato:

2023-03-10

Preparatomtale

                                Summary of Product Characteristics
CONFIDENTIAL
Bilobil capsules 120 mg
VOL: 1; P: 10 / 33
PI_Text037101_1
– Updated:
Page 1 of 6
1.
NAME OF THE MEDICINAL PRODUCT
Bilobil intense 120 mg capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each hard capsule contains 120 mg of extract (as dry extract, refined
and quantified) from _Ginkgo _
_biloba_ L_., _folium (Ginkgo leaf) (35
–
67:1), corresponding to:
-
26.4 to 32.4 mg of flavonoids expressed as flavone glycosides,
-
3.36 to 4.08 mg of ginkgolides A, B, C and
-
3.12 to 3.84 mg of bilobalide.
Excipients: lactose (188.1 mg), glucose (6 mg).
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Capsule.
The capsules are brown. They contain a light to dark brown powder with
visible darker particles and
possible small clods.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Bilobil intense capsules are a herbal medicinal product that is
recommended for symptomatic
treatment:
-
in disturbances of cerebral circulation and function (syndrome of
dementia in primary
degenerative dementia, in vascular dementia or in a mixed form of
both) manifested as decline
in memory and intellectual capacity, vertigo, tinnitus, indisposition,
headache and sleep
disorders, general malaise;
-
in initial disturbances of blood perfusion of the extremities,
manifested as cold feet, tingling,
numbness or pain on walking.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
DISTURBANCES OF CEREBRAL CIRCULATION AND FUNCTION (SYNDROME OF
DEMENTIA IN PRIMARY
DEGENERATIVE DEMENTIA, IN VASCULAR DEMENTIA OR IN A MIXED FORM OF
BOTH):
The recommended dose is 1 capsule twice daily, in the morning and in
the evening.
INITIAL DISTURBANCES OF BLOOD PERFUSION OF THE EXTREMITIES:
The recommended dose is 1 capsule once daily, preferable in the
morning.
The capsules should be swallowed whole with some liquid. They may be
taken without regard to
meals. Concomitant intake of alcoholic beverages is not advised.
The first signs of improvement are usually observed after one month.
For a longer-lasting
                                
                                Les hele dokumentet
                                
                            

Dokumenter på andre språk

Informasjon til brukeren Informasjon til brukeren russisk 10-03-2023